Ron Waksman
Latest contributions
DCB: what we know and what we do not know
22 May 2026 – From EuroPCR 2026
This session provides a detailed update on drug-coated balloons (DCB) in interventional cardiology, covering the latest clinical data and trials. It identifies scenarios where DCB use is most effective and offers guidance on optimizing procedural techniques to enhance clinical outcomes.
Is there a rule for DCB in ACS setting?
22 May 2026 – From EuroPCR 2026
This session examines the application of drug-coated balloons (DCB) in the acute coronary syndrome (ACS) setting, comparing outcomes with drug-eluting stents (DES). It discusses the impact of intraluminal thrombus, real-world registry data on DCB-first strategies in STEMI, and multicentre experiences with DCB use in STEMI and...
Hybrid percutaneous revascularisation: combining DES and DCB for optimal results
21 May 2026 – From EuroPCR 2026
This session delves into hybrid percutaneous revascularisation techniques that combine drug-eluting stents (DES) and drug-coated balloons (DCB) to achieve optimal clinical results. It highlights the clinical and anatomical scenarios suited for hybrid PCI, provides a step-by-step procedural approach, and discusses the potential benefits of integrating these...
Is DCB a new valid option for coronary revascularisation?
22 May 2025 – From EuroPCR 2025
This session provides an in-depth evaluation of drug-coated balloons (DCB) as a valid option for coronary revascularisation. Topics include two-year follow-up comparisons between paclitaxel and sirolimus-coated balloons, clinical outcomes after bailout stenting post-DCB angioplasty, meta-analyses contrasting DCB and DES for large native coronary artery disease, and...
Stent technologies, last evidence in coronary interventions
21 May 2025 – From EuroPCR 2025
Update your knowledge on the latest stent technologies and clinical evidence in coronary interventions. This session reviews long-term outcomes of resorbable magnesium scaffolds, seven-year data from the COMPARE-ABSORB trial, bioadaptor versus stent comparisons, dual therapy sirolimus-eluting versus biolimus-eluting stents, and randomized trials on direct stenting versus...
Challenges in acute coronary syndrome treatment
16 May 2024 – From EuroPCR 2024
This session delves into the challenges and emerging insights in the treatment of acute coronary syndrome (ACS). It features presentations and discussions on topics such as sex-based differences in treatment and outcomes in STEMI, the use of ticagrelor de-escalation strategy in CKD patients, the outcomes of...
Mitral and tricuspid hotline
16 May 2024 – From EuroPCR 2024
This session provides updates on the latest developments in transcatheter mitral and tricuspid valve interventions. Key topics include one-year outcomes of the MiCLASP study on transcatheter mitral repair, the impact of residual mitral and tricuspid regurgitation after transcatheter repair, and the early feasibility of the AltaValve...
Management of patient with complex left main stenosis - LIVE case
14 May 2024 – From EuroPCR 2024
A 52-year-old male, with a history of STEMI treated by PPCI on RCA one month ago, presents with angina CCS 2 and severe, calcified stenosis in the LAD, CX, and distal left main. The treatment involved implanting 2 stents in the LAD after Rota preparation, followed...
EuroPCR 2023 Hotlines/Late-Breaking Trials: focus on stent technology
17 May 2023 – From EuroPCR 2023
If you would like to learn more about the latest findings on stent techhnology, check-out this session in which speakers reviewed a series of recent trials, among them: 12-month primary endpoint outcomes of the BIOADAPTOR-RCT; Final 5-year results from the blinded ABSORB IV trial ; BIOMAG-I:...
Bifurcation with provisional stent strategy - LIVE case
17 May 2023 – From EuroPCR 2023
Learn more about a 65-year-old diabetic male patient with BMI 31, NYHA III shortness of breath, and a mid-calcified lesion on proximal and mid-part of LAD. QFR and µFR were significant for the 2 LAD lesions (0.73 and 0.74). The proximal lesion was a bifurcation Medina 1-0-1...
PCR's Got Talent-Round 3
19 May 2022 – From EuroPCR 2022
Watch the abstracts of the 3rd round of PCR's Got Talent, a unique competition for young practitioners, to discover more about Plaque burden assessment from OCT with deep learning, HALT: an independent predictor of structural valve deterioration and much more!
PCR Innovators Day - Follow-up and technology updates
19 May 2022 – From EuroPCR 2022
In this EuroPCR 2022 session, find out more about how mastering heart failure treatment by empowering physicians and patients, discover a novel approach for fluid removal, an adjustable interatrial shunt system, and much more!
PCR's Got Talent - Round 2 - Session 1
18 May 2022 – From EuroPCR 2022
Consult this session to discover the abstracts submitted during the second round of EuroPCR 2022 PCR's Got Talent, a unique abstract competition for young practitioners.
PCI for severe calcified lesions
18 May 2022 – From EuroPCR 2022
This session presents, LIVE from Toulouse, France, the management of a calcified LCx lesion in a 74-year-old patient with hypertension and NIDDM, scheduled for hip replacement surgery, and highlights the role of IVUS in optimising final angiographic results.
The current role of paclitaxel DCB in PCI
18 May 2022 – From EuroPCR 2022
Thanks to the different interventions of this EuroPCR 2022 session, understand the role of paclitaxel DCB in modern era interventional cardiology, the differences, and advantages versus DES, the role of blended therapies in CLS, and learn how to correctly prepare the lesion and obtain the best from this technology on...
PCR's Got Talent - Round 1 - Session 1
17 May 2022 – From EuroPCR 2022
Consult this session to discover a selection of cases presented during the round 1 of PCR's Got Talent at EuroPCR 2022: DAPT modulation after PCI for ACS, plaque burden assessment from OCT with deep learning, prognosis of myocardial infarction in patients with cancer, and much more!
